Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. Monday, Viatris and Amphastar Pharmaceuticals both said they have received the FDA’s ...

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed! ore than 360 people fell ...

With three new antibiotics set to shake up the stagnant treatment landscape for uncomplicated urinary tract infections (uUTIs) in the U.S., Dublin-based Iterum Therapeutics has made it to market first ...

Novartis could lose years of patent protection in the US for its blockbuster multiple sclerosis therapy Gilenya, after a federal appeals verdict went against the company. The litigation revolves ...

The Food and Drug Administration signed off on the first-ever weight-loss generic on Thursday, a knockoff of Novo Nordisk'sNVO Saxenda from Teva PharmaceuticalTEVA. Saxenda, the branded name for ...

Aug 20 (Reuters) - India's Aurobindo Pharma (ARBN.NS), opens new tab is leading the race to buy Prague-based drugmaker Zentiva (1SKF401E.BV), opens new tab for up to $5.5 billion, the Economic Times ...

Something has gone badly wrong in the public service. From energy policy to financial regulation to education, ministers are too often advised by officials lacking the deep technical background their ...

Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead to improved access by NHS patients to mRNA-based vaccines and drug treatments. The facility is the ...